Cases 11 - 20 of 323
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2023cv00551
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
as 1:2023cv00374
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
as 1:2023cv00362
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC.
as 1:2023cv01505
Plaintiff:
CORCEPT THERAPEUTICS, INC.
Defendant:
TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICALS INDUSTRIES LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv01190
Counter Defendant:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Counter Claimant:
TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv00133
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
